Screening Shift: The FDA has green-lit America's first at-home cervical cancer screening device, potentially transforming women's preventive care. Similar self-collection methods have already boosted screening rates in countries like Australia. With an estimated 13,360 new cervical cancer cases and 4,320 deaths expected in 2025, experts believe this innovation could significantly ramp up screenings among women who avoid traditional pap smears due to discomfort, stigma, or logistical barriers.
https://interestingengineering.com/health/fda-oks-first-at-home-cervical-cancer-test